Home JAK/STAT JAK inhibitor AZD1480

AZD1480

Catalog No.S2162

For research use only.

AZD1480 is a novel ATP-competitive JAK2 inhibitor with IC50 of 0.26 nM in a cell-free assay, selectivity against JAK3 and Tyk2, and to a smaller extent against JAK1. Phase 1.

AZD1480 Chemical Structure

CAS No. 935666-88-9

Selleck's AZD1480 has been cited by 100 publications

Purity & Quality Control

Choose Selective JAK Inhibitors

Related Compound Libraries

Other JAK Products

Download Inhibitor Catalog

Download Inhibitor Catalog
JAK Signaling Pathways

JAK Signaling Pathway Map

Biological Activity

Description AZD1480 is a novel ATP-competitive JAK2 inhibitor with IC50 of 0.26 nM in a cell-free assay, selectivity against JAK3 and Tyk2, and to a smaller extent against JAK1. Phase 1.
Targets
JAK2 [1]
(Cell-free assay)
0.26 nM
In vitro

5μM AZD1480 induces G2/M arrest and cell death by inhibiting Aurora kinases. [1] AZD1480 is a potent JAK2 inhibitor that can suppress growth, survival, as well as FGFR3 and STAT3 signaling and downstream targets including Cyclin D2 in human multiple myeloma cells. At low micromolar concentrations, AZD1480 blocks cell proliferation and induces apoptosis of myeloma cell lines. [2]AZD1480 effectively blocks constitutive and stimulus-induced JAK1, JAK2, and STAT-3 phosphorylation in both human and murine glioma cells, and leads to a decrease in cell proliferation and induction of apoptosis. [3]AZD1480 is a potent, competitive small-molecule inhibitor of JAK1/2 kinase, and that it is capable of inhibiting STAT3 phosphorylation and tumor growth in a STAT3-dependent manner. AZD1480 inhibits tumor angiogenesis and metastasis in part by affecting the tumor microenvironment. [4]
Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
SW620 NUnHRY5CTnWwY4Tpc44hSXO|YYm= M1XETFUh|ryP NYDwTWp{PDhiaB?= NFzaTIdFVVOR MYjicI9kc3NiSlHLNk9UXEGWMzDzbYdv[Wyrbne= MmXGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV7NUS5O|QoRjJ3OUW0PVc1RC:jPh?=
LoVo  MW\GeY5kfGmxbjDBd5NigQ>? MlPTOUDPxE1? NV\uUWdzPDhiaB?= NUTlXYl7TE2VTx?= NGjETFVjdG:la4OgTmFMOi:VVFHUN{B{cWewYXzpcoc> MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTl3NEm3OEc,OjV7NUS5O|Q9N2F-
HN5 MnKzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1;5[lczKGh? NXXGfJhYTUN3ME2zMlgyKMLzIEGuPVkh|ryP M2\vPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEGwNFExLz5{NUixNFAyODxxYU6=
Cal33 NUDtSm9rT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnrPO|IhcA>? NEfvVYtGSzVyPUOuN|chyrFiMD63OUDPxE1? MmnZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6MUCwNVAoRjJ3OEGwNFExRC:jPh?=
UM-22B NFvrSlVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHHURmo4OiCq NVXKToNDTUN3ME2yMlY3KMLzIECuNlQh|ryP NV7iXG5mRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4NVAxOTBpPkK1PFExODFyPD;hQi=>
686LN MnnsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVfFc2Y5PzJiaB?= NYHQOWRuTUN3ME2yMlA2KMLzIEGuN|Mh|ryP M2WxWFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEGwNFExLz5{NUixNFAyODxxYU6=
UM SCC-1 M4DSb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVri[XB4PzJiaB?= MYTFR|UxRTFwNkegxtEhOC52MjFOwG0> MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPThzMECxNEc,OjV6MUCwNVA9N2F-
UM-22A MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUTydVlkPzJiaB?= NX7FOWo1TUN3ME2xMlMzKMLzIECuN|kh|ryP MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPThzMECxNEc,OjV6MUCwNVA9N2F-
OSC19 NFrhZoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYq3NkBp Mm\lSWM2OD1zLkK2JOKyKDBwMkCg{txO MlHJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6MUCwNVAoRjJ3OEGwNFExRC:jPh?=
PCI-52 M1nQeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGLLbm44OiCq M1iyb2VEPTB;MT6wNEDDuSByLkC5JO69VQ>? MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPThzMECxNEc,OjV6MUCwNVA9N2F-
PCI-15B MoXDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkO0O|IhcA>? M2jjNWVEPTB;MD65PUDDuSBzLke0JO69VQ>? NYXwZYxORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4NVAxOTBpPkK1PFExODFyPD;hQi=>
UMSCC-1 MYjGeY5kfGmxbjDBd5NigQ>? MV:wMlAxODVvMT62JO69VQ>? MWmyOEBp NETITpVi[nKxZ3H0[ZMhUUxvNvMAl4lv\HWlZXSgeZAuemWpdXzheIlwdiCxZjDwV3RCXDOWeYK3NFXDqGmwIHGg[I9{\S2mZYDlcoRmdnRibXHucoVz MmjaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6MUCwNVAoRjJ3OEGwNFExRC:jPh?=
Cal33 MU\GeY5kfGmxbjDBd5NigQ>? MXOwMlAxODVvMz64JO69VQ>? MWSyOEBp NFfzTVJi[nKxZ3H0[ZMhUUxvNvMAl4lv\HWlZXSgeZAuemWpdXzheIlwdiCxZjDwV3RCXDOWeYK3NFXDqGmwIHGg[I9{\S2mZYDlcoRmdnRibXHucoVz MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPThzMECxNEc,OjV6MUCwNVA9N2F-
HH5 M4T2WWZ2dmO2aX;uJGF{e2G7 M2G3[VAvODByNT2zMlgh|ryP MoftNlQhcA>? MXLhZpJw\2G2ZYOgTWwuPuLCk3nu[JVk\WRidYCtdoVofWyjdHnvckBw\iCyU2TBWFNVgXJ5MEZCpIlvKGFiZH;z[U1l\XCnbnTlcpQhdWGwbnXy NFrz[2k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUixNFAyOCd-MkW4NVAxOTB:L3G+
UM-22A NYrsboYyTnWwY4Tpc44hSXO|YYm= M2XLb|AvODByNT2xMlYh|ryP NIXJc3YzPCCq MWnhZpJw\2G2ZYOgTWwuPuLCk3nu[JVk\WRidYCtdoVofWyjdHnvckBw\iCyU2TBWFNVgXJ5MEZCpIlvKGFiZH;z[U1l\XCnbnTlcpQhdWGwbnXy NWXWXIR4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4NVAxOTBpPkK1PFExODFyPD;hQi=>
A1847 NFrlc4VHfW6ldHnvckBCe3OjeR?= M2TU[FAvODVvMUCg{txO Mn3RNlQhcA>? NH\sUY9FVVORwrC= M1K1[pJm\HWlZYOgdIhwe3Cqb4L5cIF1\WRiU2TBWFMhdGW4ZXzz M3jOPVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkS2NFE2Lz5{NU[0OlAyPTxxYU6=
OVCAR-5 NYXIToNYTnWwY4Tpc44hSXO|YYm= NXLnbYNoOC5yNT2xNEDPxE1? NV7ORpNKOjRiaB?= MYDEUXNQyqB? M3TNc5Jm\HWlZYOgdIhwe3Cqb4L5cIF1\WRiU2TBWFMhdGW4ZXzz MlKyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4NE[wNVUoRjJ3NkS2NFE2RC:jPh?=
OVCAR-8 NXPTXoprTnWwY4Tpc44hSXO|YYm= NW\FcIU2OC5yNT2xNEDPxE1? NYTRbVk1OjRiaB?= M4fuSmROW00EoB?= NX3nXWFremWmdXPld{BxcG:|cHjvdplt[XSnZDDTWGFVOyCuZY\lcJM> NXL4PZd2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2OFYxOTVpPkK1OlQ3ODF3PD;hQi=>
MOVCAR-5447 Mm\lSpVv[3Srb36gRZN{[Xl? NGnieo0xNjB3LUGwJO69VQ>? MXWyOEBp NHK3WGpFVVORwrC= MkG4doVlfWOnczDwbI9{eGixconsZZRm\CCVVFHUN{Bt\X[nbIO= NHTSeZU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NU[0OlAyPSd-MkW2OFYxOTV:L3G+
MOVCAR-5009 Mn;rSpVv[3Srb36gRZN{[Xl? MnHENE4xPS1zMDFOwG0> MnjUNlQhcA>? M4TRTGROW00EoB?= NWfVUFd4emWmdXPld{BxcG:|cHjvdplt[XSnZDDTWGFVOyCuZY\lcJM> NVe2VlFWRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2OFYxOTVpPkK1OlQ3ODF3PD;hQi=>
A1847 M1yySmNmdGxiVnnhZoltcXS7IFHzd4F6 NGD1[msxNjB3LUGwJO69VQ>? NHnlOFk4OiCq M3nwV2ROW09? MXvy[YR2[2W|IHPlcIwhfmmjYnnsbZR6KGG2IITo[UBkd26lZYLueJJifGmxbjDv[kA2KM7:TR?= M4LuXlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkS2NFE2Lz5{NU[0OlAyPTxxYU6=
OVCAR-5 NUi5PYd2S2WubDDWbYFjcWyrdImgRZN{[Xl? NYHKRm1WOC5yNT2xNEDPxE1? NHHFfGw4OiCq M2jtR2ROW09? MUjy[YR2[2W|IHPlcIwhfmmjYnnsbZR6KGG2IITo[UBkd26lZYLueJJifGmxbjDv[kA2KM7:TR?= M{jWTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkS2NFE2Lz5{NU[0OlAyPTxxYU6=
OVCAR-8  MYLD[YxtKF[rYXLpcIl1gSCDc4PhfS=> MXqwMlA2NTFyIN88US=> NXP1dlJpPzJiaB?= NFTDcIRFVVOR NFLieo5z\WS3Y3XzJINmdGxidnnhZoltcXS7IHH0JJRp\SClb37j[ZJvfHKjdHnvckBw\iB3IN88US=> Mo\CQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4NE[wNVUoRjJ3NkS2NFE2RC:jPh?=
OVCAR-5  MmH4RZBweHSxc3nzJGF{e2G7 NYTtbGU2OC53L{GvOUDPxE1? MUi0PEBp MnjiSG1UVw>? M1P4eIlv\HWlZYOgd4lodmmoaXPhcpQh[XCxcITvd4l{KGG2IHjp[4gh[2:wY3XycpRz[XSrb36= NXrnVlhuRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2OFYxOTVpPkK1OlQ3ODF3PD;hQi=>
OVCAR-8  NX7PNVlySXCxcITvd4l{KEG|c3H5 MWCwMlUwOS93IN88US=> MoX4OFghcA>? Mn[wSG1UVw>? MUPpcoR2[2W|IIPp[45q\mmlYX70JIFxd3C2b4Ppd{BifCCqaXfoJINwdmOncn70doF1cW:w M3;1PFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkS2NFE2Lz5{NU[0OlAyPTxxYU6=
AKRSL NIjWeI9E\WyuIG\pZYJqdGm2eTDBd5NigQ>? NHTMOYk4OiCq NGfr[llKSzVy78{eNVAh|ryP Mn73QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV3MES2N|UoRjJ3NUC0OlM2RC:jPh?=
PALJDL MWHD[YxtKF[rYXLpcIl1gSCDc4PhfS=> NWPDNolMPzJiaB?= NHzYe2RKSzVyPUKuOEDPxE1? MoT4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV3MES2N|UoRjJ3NUC0OlM2RC:jPh?=
MO4 MV3GeY5kfGmxbjDBd5NigQ>? MojkNE42NzFxNTFOwG0> MVe2JIg> NFHoNmlqdmirYnn0d{BRNVOWQWSzJIV5eHKnc4Ppc47DqA>? NU\CbFlKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxOFk2OzVpPkK1NVQ6PTN3PD;hQi=>
DU145  MUfGeY5kfGmxbjDBd5NigQ>? Mn3VNE0zODBibl2= NITDU4YyKGkEoB?= M3TPeJN2eHC{ZYPz[ZMhUUxvNj3hZ5RqfmG2ZXSgV5RifDNiYX7kJGVTUzFxMjDzbYdv[Wyrbne= MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDV5N{m0Nkc,OjR3N{e5OFI9N2F-
DU145  NIH1N5NHfW6ldHnvckBCe3OjeR?= M1qwZlgxOCCwTR?= MX:3NkBp M4LkXZN2eHC{ZYPz[ZMhUUxvNj3pcoR2[2WmIH3p[5JifG:{eR?= NHzYZpg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEW3O|k1Oid-MkS1O|c6PDJ:L3G+
CWR22Rv1 MnjFSpVv[3Srb36gRZN{[Xl? MlO3PFAxKG6P MmO2O|IhcA>? NV;WN5VSe3WycILld5NmeyCLTD22MYlv\HWlZXSgcYloemG2b4L5 NXTjWIM4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS1O|c6PDJpPkK0OVc4QTR{PD;hQi=>
N592 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4TYWmlEPTB;MD64OEDPxE1? MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDF3OEewNUc,OjRzNUi3NFE9N2F-
H82 NWTT[2o{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV;JR|UxRTFwM{eg{txO NWXyPWt{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSxOVg4ODFpPkK0NVU5PzBzPD;hQi=>
GLC4 MnrJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV3JR|UxRTFwN{mg{txO Mn\IQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjRzNUi3NFEoRjJ2MUW4O|AyRC:jPh?=
H526 NIPOfndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{Dab2lEPTB;Mz6wPEDPxE1? M4TYZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2MUW4O|AyLz5{NEG1PFcxOTxxYU6=
H1173 NX3NSlZvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUTJR|UxRTJwM{mg{txO MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDF3OEewNUc,OjRzNUi3NFE9N2F-
DMS114 Mk[wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkCwTWM2OD1yLkezJO69VQ>? M3O3RlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2MUW4O|AyLz5{NEG1PFcxOTxxYU6=
NCI-N592 NF\sS|BHfW6ldHnvckBCe3OjeR?= NWniVow{OC5|L{GvN{DPxE1? NWPqXHc5OjRiaB?= MlHhbY5lfWOnczDHNk9OKGOnbHygZ5lkdGViYYLy[ZN1 Mn;CQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjRzNUi3NFEoRjJ2MUW4O|AyRC:jPh?=
GLC4 MY\GeY5kfGmxbjDBd5NigQ>? MmO2NE4{NzFxMzFOwG0> MXSyOEBp MmLybY5lfWOnczDHNk9OKGOnbHygZ5lkdGViYYLy[ZN1 MoG3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjRzNUi3NFEoRjJ2MUW4O|AyRC:jPh?=
NCI-H82 NF7adWxHfW6ldHnvckBCe3OjeR?= M1rYb|AvOy9zL{Og{txO MYqyOEBp NWrveoIzcW6mdXPld{BIOi:PIHPlcIwh[3mlbHWgZZJz\XO2 M3vi[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2MUW4O|AyLz5{NEG1PFcxOTxxYU6=
NCI-N592 NEDBRW9CeG:ydH;zbZMhSXO|YYm= Ml;wNE4{NzFxMzFOwG0> MVW0PEBp MXzpcoNz\WG|ZYOgeIhmKGyndnXsJI9nKGOuZXH2[YQuS2G|cHHz[UA{ Mlm4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjRzNUi3NFEoRjJ2MUW4O|AyRC:jPh?=
GLC4 MXzBdI9xfG:|aYOgRZN{[Xl? MlP3NE4{NzFxMzFOwG0> MVy0PEBp MYXpcoNz\WG|ZYOgeIhmKGyndnXsJI9nKGOuZXH2[YQuS2G|cHHz[UA{ NY\KZ|FuRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSxOVg4ODFpPkK0NVU5PzBzPD;hQi=>
NCI-H82 NHX6T5pCeG:ydH;zbZMhSXO|YYm= M1fD[VAvOy9zL{Og{txO NVfUW2xpPDhiaB?= Mmn2bY5kemWjc3XzJJRp\SCuZY\lcEBw\iClbHXheoVlNUOjc4Dhd4UhOw>? NYXiSmpiRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSxOVg4ODFpPkK0NVU5PzBzPD;hQi=>
CWR22Rv1  NFP0NGZCeG:ydH;zbZMhSXO|YYm= M1znWWlEPTB;MD60PFIh|ryP MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzl2MkC5OUc,OjN7NEKwPVU9N2F-
CWR22Pc MV;BdI9xfG:|aYOgRZN{[Xl? MnrZTWM2OD1yLkSzPEDPxE1? NXO4SYFrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO5OFIxQTVpPkKzPVQzODl3PD;hQi=>
PC-3 M4\jb2Fxd3C2b4Ppd{BCe3OjeR?= MofXTWM2OD1zLke1OUDPxE1? NHzvNG49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{m0NlA6PSd-MkO5OFIxQTV:L3G+
DU145 MXjBdI9xfG:|aYOgRZN{[Xl? M1TLZ2lEPTB;Mz61NVch|ryP NUDnb|NbRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO5OFIxQTVpPkKzPVQzODl3PD;hQi=>
RC165N M{f1V2Fxd3C2b4Ppd{BCe3OjeR?= NVq5eWE1UUN3ME2yMlA5OyEQvF2= NHuwO2U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{m0NlA6PSd-MkO5OFIxQTV:L3G+
ARPE19 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVz0Z5d4TE2VTx?= M4DXPWlEPTB;MkSuN|gh|ryP MlXPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3M{G5NlEoRjJ|NUOxPVIyRC:jPh?=
HEK293 NFnhXphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1;RO2ROW09? MV7JR|UxRThwNkeg{txO MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
KCNR NUHKbG5wT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV3Nc4lGTE2VTx?= NF:3fGlKSzVyPUCuOFYh|ryP NUnxN|N5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO1N|E6OjFpPkKzOVMyQTJzPD;hQi=>
SY5Y MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1n5bGROW09? M4rHZWlEPTB;MD6zOkDPxE1? MmryQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3M{G5NlEoRjJ|NUOxPVIyRC:jPh?=
BE2 MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MofZSG1UVw>? MYHJR|UxRTBwN{Gg{txO NWOzU|BERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO1N|E6OjFpPkKzOVMyQTJzPD;hQi=>
AS NIj0bXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4TpPGROW09? M4DKd2lEPTB;MT61N{DPxE1? MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
NGP NXXGN3NVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkTWSG1UVw>? NWT2[HB5UUN3ME2wMlU3KM7:TR?= Mmf2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3M{G5NlEoRjJ|NUOxPVIyRC:jPh?=
IMR32 NHKxUppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXPEUXNQ MXzJR|UxRTBwNk[g{txO M3nJblxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUOxPVIyLz5{M{WzNVkzOTxxYU6=
LAN5 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3SyTGROW09? M37IbGlEPTB;MT6wOEDPxE1? MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
RH18 M3fxZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NELvOZpFVVOR M4K5cGlEPTB;MT60NkDPxE1? NXrORmptRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO1N|E6OjFpPkKzOVMyQTJzPD;hQi=>
RH30 NETqTphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEHwRnpFVVOR NVHBVFN7UUN3ME2xMlI2KM7:TR?= M3T0c|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUOxPVIyLz5{M{WzNVkzOTxxYU6=
RH17 MlfvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEHHWYJFVVOR NHzIPWJKSzVyPUKuOVEh|ryP NF24RYY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{WzNVkzOSd-MkO1N|E6OjF:L3G+
RH28 MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlzmSG1UVw>? MYDJR|UxRTRwMkig{txO MWC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
RH36 M1fGPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1zveGROW09? NID1OVlKSzVyPUWuN|ch|ryP MlTLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3M{G5NlEoRjJ|NUOxPVIyRC:jPh?=
RH41 NVrJTnI6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWrEUXNQ NFi2S5BKSzVyPUCuOFgh|ryP NYSwN5RtRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO1N|E6OjFpPkKzOVMyQTJzPD;hQi=>
RD M2fsc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVqyV5VvTE2VTx?= NWHpOlV{UUN3ME20MlMzKM7:TR?= MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
TC32 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWLEUXNQ MXHJR|UxRTNwOEWg{txO M{fKZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUOxPVIyLz5{M{WzNVkzOTxxYU6=
TC71 Mo\LS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MonISG1UVw>? M17DfmlEPTB;ND6zN{DPxE1? M2fj[|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUOxPVIyLz5{M{WzNVkzOTxxYU6=
KCNR MWfBdI9xfG:|aYOgRZN{[Xl? MYSwMlUwOS5yL{KuOUDPxE1? MX2yOEBp NGTXbnFFVVOR MkntbY5lfWOnczDhckBqdmO{ZXHz[UBqdiClYYPwZZNmKDNxNzDhZ5Rqfmm2eR?= M2DmVlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUOxPVIyLz5{M{WzNVkzOTxxYU6=
SY5Y MlzORZBweHSxc3nzJGF{e2G7 MknuNE42NzFwMD:yMlUh|ryP M1\WVlI1KGh? NEnh[Y1FVVOR NFLkS5ZqdmS3Y3XzJIFvKGmwY4LlZZNmKGmwIHPhd5Bie2ViMz:3JIFkfGm4aYT5 M333[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUOxPVIyLz5{M{WzNVkzOTxxYU6=
Rh18 MXzBdI9xfG:|aYOgRZN{[Xl? M{WwfFAvPS9zLkCvNk42KM7:TR?= NUHxNJVpOjRiaB?= MojPSG1UVw>? M17BV4lv\HWlZYOgZY4hcW6lcnXhd4UhcW5iY3HzdIF{\SB|L{egZYN1cX[rdIm= MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
TC32 M4DMPGFxd3C2b4Ppd{BCe3OjeR?= MojqNE42NzFwMD:yMlUh|ryP NVfqW|dQOjRiaB?= NUXQSm5JTE2VTx?= M3PUXIlv\HWlZYOgZY4hcW6lcnXhd4UhcW5iY3HzdIF{\SB|L{egZYN1cX[rdIm= M3vFdFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUOxPVIyLz5{M{WzNVkzOTxxYU6=
KCNR M4PxR2Z2dmO2aX;uJGF{e2G7 NE\mO4sxNjVxMT6wM|IvPS93IN88US=> MoXLNlQhcA>? NX3rWFdMTE2VTx?= M3;KOYlvcGmkaYTzJIJwfGhiZX7kc4dmdm:3czDjc45{fGm2dYTpeoUh[W6mIFnMMVYucW6mdXPl[EBUXEGWMzDhZ5RqfmG2aX;u NFLHXII9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{WzNVkzOSd-MkO1N|E6OjF:L3G+
SY5Y NYPB[plYTnWwY4Tpc44hSXO|YYm= NEf1fpQxNjVxMT6wM|IvPS93IN88US=> NXXYW5FPOjRiaB?= NYjnTokzTE2VTx?= NWHC[lhVcW6qaXLpeJMh[m:2aDDlcoRw\2Wwb4XzJINwdnO2aYT1eIl3\SCjbnSgTWwuPi2rbnT1Z4VlKFOWQWSzJIFkfGm4YYTpc44> M1flSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUOxPVIyLz5{M{WzNVkzOTxxYU6=
Rh18 M1;pWmZ2dmO2aX;uJGF{e2G7 NUXMPFd2OC53L{GuNE8zNjVxNTFOwG0> M{P4SFI1KGh? MmDGSG1UVw>? NIi3bY9qdmirYnn0d{Bjd3SqIHXu[I9o\W6xdYOgZ49ve3SrdIX0bZZmKGGwZDDJUE03NWmwZIXj[YQhW1SDVEOgZYN1cX[jdHnvci=> NUnoVZZuRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO1N|E6OjFpPkKzOVMyQTJzPD;hQi=>
TC32 NHrtN3JHfW6ldHnvckBCe3OjeR?= M{HSUFAvPS9zLkCvNk42NzVizszN Mnj4NlQhcA>? MVrEUXNQ NUfzWIdKcW6qaXLpeJMh[m:2aDDlcoRw\2Wwb4XzJINwdnO2aYT1eIl3\SCjbnSgTWwuPi2rbnT1Z4VlKFOWQWSzJIFkfGm4YYTpc44> MlnSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3M{G5NlEoRjJ|NUOxPVIyRC:jPh?=
TPC-1 NVuyb5V3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXmxJOK2VQ>? MUCwMVQh\A>? M2i4OGROW09? MnrzbY5pcWKrdIOgZ4VtdCCpcn;3eIgh[W[2ZYKgNkBlKHS{ZXH0cYVvfA>? NIrhW2Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{C1OlQ6QSd-MkOwOVY1QTl:L3G+
MZ-CRC1  MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2m3elEhyrWP MX6wMVUh\A>? NVjYN4U{TE2VTx?= MXPpcohq[mm2czDj[YxtKGe{b4f0bEBi\nSncjCxJIQhfHKnYYTt[Y51 NIjHbVU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{C1OlQ6QSd-MkOwOVY1QTl:L3G+
TT  NXjaeldRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUKxJOK2VQ>? NYXZZXQ1OC12IHS= MkH3SG1UVw>? MVHpcohq[mm2czDj[YxtKGe{b4f0bEBi\nSncjCxJIQhfHKnYYTt[Y51 NWXKR2lqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOwOVY1QTlpPkKzNFU3PDl7PD;hQi=>
TPC-1 MUHGeY5kfGmxbjDBd5NigQ>? NHnmcYgyKML3TR?= NXHXTVMxPzJiaB?= NIPaem5FVVOR NGDMPY5qdmS3Y3XzJGcyKGKub3PrZYdm NUexeXhbRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOwOVY1QTlpPkKzNFU3PDl7PD;hQi=>
MZ-CRC1  M4XxcmZ2dmO2aX;uJGF{e2G7 NGX1cGoyKML3TR?= NWfn[5RvPzJiaB?= M1XJdGROW09? MULpcoR2[2W|IFexJIJtd2OtYXfl Mmi5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyNU[0PVkoRjJ|MEW2OFk6RC:jPh?=
TT  MkHWSpVv[3Srb36gRZN{[Xl? Mn61NUDDvU1? NVH5[WxZPzJiaB?= MljlSG1UVw>? M{DUZ4lv\HWlZYOgS|Eh[myxY3vh[4U> M3jjfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MEW2OFk6Lz5{M{C1OlQ6QTxxYU6=
MZ-CRC1  NXXQSIFXSXCxcITvd4l{KEG|c3H5 NV3kcIFSOSEEtV2= M{jV[|Q5KGh? MXfEUXNQ NFfiUJVqdmS3Y3XzJIFxd3C2b4Ppdy=> MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzB3NkS5PUc,OjNyNU[0PVk9N2F-
TT  NHK1bmlCeG:ydH;zbZMhSXO|YYm= M{Ti[|EhyrWP M{LQOlQ5KGh? NVroSWpOTE2VTx?= MUTpcoR2[2W|IHHwc5B1d3Orcx?= M{W3OFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MEW2OFk6Lz5{M{C1OlQ6QTxxYU6=
HD-LM2 NWTrPYxDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV[3NwKBkWh? NXK0[XVHTE2VTx?= NVjL[mFmUUN3ME23Mlg1PCEQvF2= Mnm2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ6MkmwPVQoRjJ{OEK5NFk1RC:jPh?=
L-428 NHPTXXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV:3NwKBkWh? NX\3UmlrTE2VTx?= M{CzTGlEPTB;Nz65OFch|ryP MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjh{OUC5OEc,OjJ6MkmwPVQ9N2F-
KM-H2 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUO5WY1HPzMkgJno NVrBPZBDTE2VTx?= NVnRWJZnUUN3ME2xMlMxQCEQvF2= M{nQXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OEK5NFk1Lz5{MkiyPVA6PDxxYU6=
L-540 M4ryZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHS5THU4OuLCiXi= NVjuN|BVTE2VTx?= MofPTWM2OD16LkKxOkDPxE1? Mm\JQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ6MkmwPVQoRjJ{OEK5NFk1RC:jPh?=
HD-LM2 MVfGeY5kfGmxbjDBd5NigQ>? MYewMlEwOC53L{GvOUDPxE1? M4S5VVcz6oDLaB?= NVLJVZZuTE2VTx?= NFPFN3BqdmirYnn0d{BUXEGWMzygV3RCXDViYX7kJHNVSVR4IIDoc5NxcG:{eXzheIlwdg>? MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjh{OUC5OEc,OjJ6MkmwPVQ9N2F-
L-428 NXLBTJFOTnWwY4Tpc44hSXO|YYm= NXnIT4NUOC5zL{CuOU8yNzVizszN NUSwVFZUPzMkgJno MkjFSG1UVw>? M2HKNolvcGmkaYTzJHNVSVR|LDDTWGFVPSCjbnSgV3RCXDZicHjvd5Bpd3K7bHH0bY9v MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjh{OUC5OEc,OjJ6MkmwPVQ9N2F-
KM-H2 MVLGeY5kfGmxbjDBd5NigQ>? NYLodo45OC5zL{CuOU8yNzVizszN NXzuXHFTPzMkgJno MXfEUXNQ NXnVeHhkcW6qaXLpeJMhW1SDVEOsJHNVSVR3IHHu[EBUXEGWNjDwbI9{eGixconsZZRqd25? MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjh{OUC5OEc,OjJ6MkmwPVQ9N2F-
L-540 MULGeY5kfGmxbjDBd5NigQ>? NF;VO4ExNjFxMD61M|EwPSEQvF2= MmLDO|LjiImq M{LDZ2ROW09? M1n2[YlvcGmkaYTzJHNVSVR|LDDTWGFVPSCjbnSgV3RCXDZicHjvd5Bpd3K7bHH0bY9v M3rrS|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OEK5NFk1Lz5{MkiyPVA6PDxxYU6=
HD-LM2 Mn;qRZBweHSxc3nzJGF{e2G7 MlXENU82KM7:TR?= M{i3fVcz6oDLaB?= NXzqSW1MTE2VTx?= NEHYSI5qdmS3Y3XzJIFxd3C2b4Ppdy=> NWX4Z|VkRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK4NlkxQTRpPkKyPFI6ODl2PD;hQi=>
L-428 NUHBO2pESXCxcITvd4l{KEG|c3H5 MXmxM|Uh|ryP M4nSeFcz6oDLaB?= NWLqW5lOTE2VTx?= NXnKfoxQcW6mdXPld{BieG:ydH;zbZM> NUjNdJRIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK4NlkxQTRpPkKyPFI6ODl2PD;hQi=>
KM-H2 MkHrRZBweHSxc3nzJGF{e2G7 M{HaXVEwPSEQvF2= NXK0cXY6PzMkgJno MonmSG1UVw>? MX\pcoR2[2W|IHHwc5B1d3Orcx?= M{HMSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OEK5NFk1Lz5{MkiyPVA6PDxxYU6=
L-540 M3G3SmFxd3C2b4Ppd{BCe3OjeR?= MorsNU82KM7:TR?= NGPiZYE4OuLCiXi= MYTEUXNQ M4DPOolv\HWlZYOgZZBweHSxc3nz M1K4TlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OEK5NFk1Lz5{MkiyPVA6PDxxYU6=
U251-MG Mnj4SpVv[3Srb36gRZN{[Xl? M3jKeFEhyrWP MUCwMVE3KGh? MWTpcohq[mm2czDjc45{fGm2dYTpeoUhW1SDVD2zJIFv\CCMQVuyJIFkfGm4YYTpc44> NHnpeJY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkCyO|Y6OSd-MkKwNlc3QTF:L3G+
U87-MG M{\1TmZ2dmO2aX;uJGF{e2G7 NYPFb5VSOSEEtV2= MXiwMVE3KGh? NITZOIZqdmirYnn0d{Bkd26|dHn0eZRqfmViU2TBWE0{KGGwZDDKRWszKGGldHn2ZZRqd25? Mkj6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJyMke2PVEoRjJ{MEK3OlkyRC:jPh?=
4C8 M4HTXWZ2dmO2aX;uJGF{e2G7 NYrGb2tSOSEEtV2= NV7EXJFWOC1zNjDo MVvpcohq[mm2czDjc45{fGm2dYTpeoUhW1SDVD2zJIFv\CCMQVuyJIFkfGm4YYTpc44> MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjB{N{[5NUc,OjJyMke2PVE9N2F-
U251-MG Mo\lS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFL6WHYyNzFyINM1US=> M2TZR|I1NzR6L{eyJIg> M1i5TYlvcGmkaYTzJINmdGxicILvcIln\XKjdHnvckBifCCjIHPvcoNmdnS{YYTpc44hd2ZiMUCgxtVO MoTvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJyMke2PVEoRjJ{MEK3OlkyRC:jPh?=
U87-MG NULReWVGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NX3nO5l{OS9zMDFCuW0> M2TOcVI1NzR6L{eyJIg> MWnpcohq[mm2czDj[YxtKHC{b3zp[oVz[XSrb36gZZQh[SClb37j[Y51emG2aX;uJI9nKDFyINM1US=> MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjB{N{[5NUc,OjJyMke2PVE9N2F-
4C8 M{Ln[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MX2xM|ExKML3TR?= NVrydIttOjRxNEivO|IhcA>? MoXGbY5pcWKrdIOgZ4VtdCCycn;sbYZmemG2aX;uJIF1KGFiY3;uZ4VvfHKjdHnvckBw\iBzMDFCuW0> Mn3LQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJyMke2PVEoRjJ{MEK3OlkyRC:jPh?=
U266 M1r6OGFxd3C2b4Ppd{BCe3OjeR?= NGeyWJgxNjVvMjFOwG0> MYS0PE84OiCq NUWwZ2JMcW6mdXPld{BieG:ydH;zbZMh\G:|ZTDk[ZBmdmSnboTsfS=> Mkj4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFzNkS1NVcoRjJzMU[0OVE4RC:jPh?=
Kms.11 NYXKdnBpSXCxcITvd4l{KEG|c3H5 MWGwMlUuOiEQvF2= MXO0PE84OiCq NU\Re4lScW6mdXPld{BieG:ydH;zbZMh\G:|ZTDk[ZBmdmSnboTsfS=> M{XyT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMU[0OVE4Lz5{MUG2OFUyPzxxYU6=
8226 MVLBdI9xfG:|aYOgRZN{[Xl? MYqwMlUuOiEQvF2= M4i2UFQ5Nzd{IHi= MlLqbY5lfWOnczDhdI9xfG:|aYOg[I9{\SCmZYDlcoRmdnSueR?= NYC2dYhRRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGxOlQ2OTdpPkKxNVY1PTF5PD;hQi=>
SET2 NF62dIdIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MkfyOFghcHK| MVrHdo94fGhiaX7obYJqfGmxbjDv[kBpfW2jbjDTSXQzKGOnbHzzJIV5eHKnc4PpcochUmGtMjDWOlE4TiCvdYThcpQh[W[2ZYKgOFghcHK|IHL5JG1VWyCjc4PhfUwhT0l3MDC9JFAvODF4IN88UU4> NF30fZE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUGzPFI1Pid-MkGxN|gzPDZ:L3G+
SET2 NIrUU3RHfW6ldHnvckBie3OjeR?= NVu0eYVHOSCqch?= M2LMZ2lvcGmkaYTpc44hd2ZiU4TheFMheGixc4Doc5J6dGG2aX;uJIlvKGi3bXHuJHNGXDJiY3XscJMh[W[2ZYKgNUBpeiCkeTDX[ZN1\XKwIHLsc5R1cW6pLDDJR|UxKD1iMD6wNlMh|ryPLh?= MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTF|OEK0Okc,OjFzM{iyOFY9N2F-
SET2 MX\GeY5kfGmxbjDhd5NigQ>? MlzpNUBpeg>? MmPNTY5pcWKrdHnvckBw\iCVdHH0OUBxcG:|cHjvdplt[XSrb36gbY4hcHWvYX6gV2VVOiClZXzsd{Bi\nSncjCxJIhzKGK7IGfld5Rmem5iYnzveJRqdmduIFnDOVAhRSByLkCyOUDPxE1w MnnPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFzM{iyOFYoRjJzMUO4NlQ3RC:jPh?=
HEL MnH4SpVv[3Srb36gZZN{[Xl? MkOyNUBpeg>? MXjJcohq[mm2aX;uJI9nKFO2YYS1JJBpd3OyaH;yfYxifGmxbjDpckBpfW2jbjDISWwh[2WubIOgZYZ1\XJiMTDodkBjgSCZZYP0[ZJvKGKub4T0bY5oNCCLQ{WwJF0hOC5yNEGg{txONg>? MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTF|OEK0Okc,OjFzM{iyOFY9N2F-
Ba/F3 Ml[xSpVv[3Srb36gZZN{[Xl? M4HNO2lvcGmkaYTpc44hd2ZiU4TheFUheGixc4Doc5J6dGG2aX;uJIlvKG2xdYPlJGJiN0Z|IHPlcIx{KGW6cILld5NqdmdiVFXMMWpiczJuIFnDOVAhRSByLkC0OkDPxE1w M3vBNlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMUO4NlQ3Lz5{MUGzPFI1PjxxYU6=
UKE1 MoXiS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NXX1eY5DPDhiaILz MlXsS5Jwf3SqIHnubIljcXSrb36gc4YhcHWvYX6gWWtGOSClZXzsd{BmgHC{ZYPzbY5oKEqja{KgWlYyP0ZibYX0ZY51KGGodHXyJFQ5KGi{czDifUBOXFNiYYPzZZktKEeLNUCgQUAxNjB3NDFOwG0v NVzHXmRqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGxN|gzPDZpPkKxNVM5OjR4PD;hQi=>
BA/F3 MWrHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? Mn[xOFghcHK| NVHacZFlT3Kxd4ToJIlvcGmkaYTpc44hd2ZibX;1d4UhSkFxRkOgZ4VtdHNiZYjwdoV{e2mwZzDU[YwuUkGNMjDrbY5ie2ViYX\0[ZIhPDhiaILzJIJ6KE2WUzDhd5NigSxiR1m1NEA:KDBwME[g{txONg>? Mmi2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFzM{iyOFYoRjJzMUO4NlQ3RC:jPh?=
HEL MkfhSpVv[3Srb36gZZN{[Xl? MnnqNUBpeg>? MVrJcohq[mm2aX;uJI9nKFO2YYSzJJBpd3OyaH;yfYxifGmxbjDpckBpfW2jbjDISWwh[2WubIOgZYZ1\XJiMTDodkBjgSCZZYP0[ZJvKGKub4T0bY5oNCCLQ{WwJF0hOC5yODFOwG0v NETRRYc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUGzPFI1Pid-MkGxN|gzPDZ:L3G+
HEL Ml\CS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? M2jNV|Q5KGi{cx?= MX;Hdo94fGhiaX7obYJqfGmxbjDv[kBpfW2jbjDISWwh[2WubIOg[ZhxemW|c3nu[{BL[Wt{IG[2NVdHKG23dHHueEBi\nSncjC0PEBpenNiYomgUXRUKGG|c3H5MEBIUTVyIE2gNE4{QSEQvF2u MojsQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFzM{iyOFYoRjJzMUO4NlQ3RC:jPh?=
BA/F3 MYTHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NYnwTWtrPDhiaILz NWLab|k6T3Kxd4ToJIlvcGmkaYTpc44hd2ZibX;1d4UhSkFxRkOgZ4VtdHNiZYjwdoV{e2mwZzDU[YwuUkGNMTDrbY5ie2ViYX\0[ZIhPDhiaILzJIJ6KE2WUzDhd5NigSxiR1m1NEA:KDBwNzFOwG0v MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTF|OEK0Okc,OjFzM{iyOFY9N2F-
BA/F3 MVXHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? Mn[zOFghcHK| M1\nR2dzd3e2aDDpcohq[mm2aX;uJI9nKG2xdYPlJGJCN0Z|IHPlcIx{KGW6cILld5NqdmdiVHXsMXR6czJia3nuZZNmKGGodHXyJFQ5KGi{czDifUBOXFNiYYPzZZktKEeLNUCgQUAzKM7:TT6= NHPVWm49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUGzPFI1Pid-MkGxN|gzPDZ:L3G+
BA/F3 NEK5eFlIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NGezdHU1QCCqcoO= NEDOW2lIem:5dHigbY5pcWKrdHnvckBw\iCvb4Xz[UBDSS:IMzDj[YxteyCneIDy[ZN{cW6pIGTlcE1LSUt|IHvpcoF{\SCjZoTldkA1QCCqcoOgZpkhVVSVIHHzd4F6NCCJSUWwJF0hOi5zIN88UU4> NYfkUYR3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGxN|gzPDZpPkKxNVM5OjR4PD;hQi=>
UKE1 M1nXeGZ2dmO2aX;uJIF{e2G7 MX[xJIhz MlLmTY5pcWKrdHnvckBw\iCVdHH0OUBxcG:|cHjvdplt[XSrb36gbY4hcHWvYX6gWWtGOSClZXzsd{Bi\nSncjCxJIhzKGK7IGfld5Rmem5iYnzveJRqdmd? MojQQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFzM{iyOFYoRjJzMUO4NlQ3RC:jPh?=
SW620 MYHD[YxtKGO7Y3zlJIF{e2G7 M2jYPFMvOyC3TR?= Moe2NlQhcHK| NEHPN41E\WyuIHP5Z4xmKGG{cnXzeEBqdiCqdX3hckBUXzZ{MDDj[YxteyCjc4Pld5Nm\CCjczDhZ4N2dXWuYYTpc44h[XRiR{KvUUBxcGG|ZTDheEA{NjNidV2gZYZ1\XJiMkSgbJJ{KGK7IH\sc5ch[3m2b33leJJ6 Mmn4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFzM{iyOFYoRjJzMUO4NlQ3RC:jPh?=
HEL NXLTT25qTnWwY4Tpc44h[XO|YYm= M2PLOFAvOyC3TR?= MVW1JI1qdnN? MVXJcohq[mm2aX;uJI9nKFO2YYS1JJBpd3OyaH;yfYxifGmxbjDpckBpfW2jbjDISWwh[2WubIOgZZQhOC5|IIXNJIFnfGW{IEWgcYlveyCkeTDX[ZN1\XKwIHLsc5R1cW6p Mln0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFzM{iyOFYoRjJzMUO4NlQ3RC:jPh?=
HEL NYD2blRITnWwY4Tpc44h[XO|YYm= MUiwMlMhfU1? MYKzNEB1dyB4MDDtbY5{ NEDGfmhKdmirYnn0bY9vKG:oIGP0ZZQ2KHCqb4PwbI9zgWyjdHnvckBqdiCqdX3hckBJTUxiY3XscJMh[XRiMD6zJJVOKGGodHXyJFMxKHSxIE[wJI1qdnNiYomgW4V{fGW{bjDicI91fGmwZx?= NVK2S|A6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGxN|gzPDZpPkKxNVM5OjR4PD;hQi=>
BA/F3 NX7MeWVsSW62aYT1cY9zKGG|c3H5 MW[zNEBu\y:tZx?= MV:xNkBpenN? MYjBcpRqfHWvb4KgZYN1cX[rdImgZYdicW6|dDDtc5V{\SCEQT;GN{Bk\WyuczDlfJBz\XO|aX7nJHRmdC2MQVuyJJhmdm:pcnHmeIVlKGmwIF7DdkBud3W|ZTDhd5Nme3OnZDDhd{Bz\WS3Y4Tpc44hd2ZicHjvd5Bpd3K7bHH0[YQhW3SjdEWgcIV3\WxiaX6gd5Bt\WWwIHH0JFMxKG2pL3vnMEBxdyCjZoTldkAyOiCqcoOgZpkhX2W|dHXyckBjdG:2dHnu[y=> MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTF|OEK0Okc,OjFzM{iyOFY9N2F-
HEL M3z5NGZ2dmO2aX;uJIF{e2G7 MX[wMlMhfU1? NEDJOIs2KG2rboO= NFHwOpZKdmirYnn0bY9vKG:oIGP0ZZQ{KHCqb4PwbI9zgWyjdHnvckBqdiCqdX3hckBJTUxiY3XscJMh[XRiMD6zJJVOKGGodHXyJFUhdWmwczDifUBY\XO2ZYLuJIJtd3S2aX7n NUDpd|Z{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGxN|gzPDZpPkKxNVM5OjR4PD;hQi=>
HEL M3\OemZ2dmO2aX;uJIF{e2G7 M4PBNFAvOyC3TR?= NWHTUG8zOzBidH:gOlAhdWmwcx?= NVTzUopNUW6qaXLpeIlwdiCxZjDTeIF1OyCyaH;zdIhwenmuYYTpc44hcW5iaIXtZY4hUEWOIHPlcIx{KGG2IECuN{B2VSCjZoTldkA{OCC2bzC2NEBucW6|IHL5JHdme3Sncn6gZoxwfHSrbne= Ml7JQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFzM{iyOFYoRjJzMUO4NlQ3RC:jPh?=
Hs578T MkDrSpVv[3Srb36gZZN{[Xl? MoTCNUB2VQ>? NVvOfWVxOjRiaILz NIXMOJJKdmirYnn0bY9vKG:oIGPURXQ{Sy2vZXTpZZRm\CC2cnHud4NzcXC2aX;uJIlvKGi3bXHuJGh{PTd6VDDj[YxteyCjdDCxJJVOKGGodHXyJFI1KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[Xl? MmXNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR7N{ixNVIoRjJ2OUe4NVEzRC:jPh?=
NCI-H1975 NIn6[nZHfW6ldHnvckBie3OjeR?= MX[wMlAxOyC2bzCzJJVO NVyyXXd3OiCqcoO= M3HxTmlvcGmkaYTpc44hd2ZiSlHLNUBqdiCqdX3hckBPS0lvSEG5O|Uh[2WubIOgZZN{\XO|ZXSgZZMhemWmdXP0bY9vKGmwIGPURXQ{KHCqb4PwbI9zgWyjdHnvckBifCByLkCwN{B1dyB|IIXNJIFnfGW{IEKgbJJ{KGK7IGfld5Rmem5iYnzveEBidmGueYPpdy=> MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjZzNESwPEc,OjZ4MUS0NFg9N2F-
HEL 92.1.7 M1PaTWZ2dmO2aX;uJIF{e2G7 MVuyJIhzew>? MkDKTY5pcWKrdHnvckBw\iCMQVuyJIlvKGi3bXHuJGhGVCB7Mj6xMlch[2WubIOgZZN{\XO|ZXSgZZMhemWmdXP0bY9vKGmwIGPURXQ2KHCqb4PwbI9zgWyjdHnvckBi\nSncjCyJIhzeyCkeTDX[ZN1\XKwIHLsc5Qh[W6jbInzbZM> NYe1b|dpRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[2NVQ1ODhpPkK2OlE1PDB6PD;hQi=>
DAOY M{XJRZFJXFNiYYPzZZk> MkL4dWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKESDT2mgZ4VtdHN? M17RXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
SJ-GBM2 NV;SbmpxeUiWUzDhd5NigQ>? NFnqeGZyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiU1qtS2JOOiClZXzsdy=> NGrTem49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
A673 NU\SWmZseUiWUzDhd5NigQ>? MmKwdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKEF4N{OgZ4VtdHN? M2PENVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
SK-N-MC NFj4W5hyUFSVIHHzd4F6 MlvtdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFONLV6tUWMh[2WubIO= M2LtTFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
BT-37 MnT0dWhVWyCjc4PhfS=> MVnxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhSlRvM{egZ4VtdHN? NX3OPItVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
NB-EBc1 NHn2dmdyUFSVIHHzd4F6 MknDdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKE6ELVXCZ|Eh[2WubIO= NEDCNo89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
Saos-2 NX:xbIY2eUiWUzDhd5NigQ>? NF;BZ4RyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiU3Hvd{0zKGOnbHzz NF\weWY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
SK-N-SH NInsO4xyUFSVIHHzd4F6 M4C4bJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVSz3OMXNJKGOnbHzz NGm3Nnc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
NB1643 MofSdWhVWyCjc4PhfS=> MlrVdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKE6EMU[0N{Bk\Wyucx?= MlW0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
BT-12 NFSxW2JyUFSVIHHzd4F6 NHXEW25yUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiQmStNVIh[2WubIO= M1;UNFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
OHS-50 M4q2Z5FJXFNiYYPzZZk> NHKyVWVyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiT1jTMVUxKGOnbHzz M1\yR|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
RD NHruNY5yUFSVIHHzd4F6 MYnxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhWkRiY3XscJM> MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
MG 63 (6-TG R) M3ftVJFJXFNiYYPzZZk> M1T4d5FJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCPRzC2N{ApPi2WRzDSLUBk\Wyucx?= NHrUcHI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
Rh41 NHrFXndyUFSVIHHzd4F6 M2q5NJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCUaESxJINmdGy| NXTvbJVGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
Click to View More Cell Line Experimental Data
Assay
Methods Test Index PMID
Western blot p-STAT3 / STAT3 / p-JAK2 / JAK2 ; p-STAT1 / STAT1 / p-STAT5 / STAT5 / p-STAT6 / STAT6 ; p-ERK / ERK / p-p38 / p38 / SOCS3 / p-SHP2 / SHP2 22027691 22829094
Immunofluorescence pSTAT5 30140255
Growth inhibition assay Cell proliferation ; Cell viability 22027691 25855603
In vivo AZD1480 inhibits the STAT3 phosphorylation in an xenograft model of human solid tumors and multiple myeloma. [1] In vivo, AZD1480 inhibits the growth of subcutaneous tumors and increases survival of mice bearing intracranial glioblastoma (GBM) tumors by inhibiting STAT-3 activity, indicating that pharmacologic inhibition of the JAK/STAT-3 pathway by AZD1480 should be considered for study in the treatment of patients with GBM tumors. [3]AZD1480 blocks lung infiltration of myeloid cells and formation of pulmonary metastases in both mouse syngeneic experimental and spontaneous metastatic models. Furthermore, AZD1480 reduces angiogenesis and metastasis in a human xenograft tumor model. [4] The Jak2 inhibitor, AZD1480, suppresses the growth of human solid tumor xenografts harboring persistent Stat3 activity. [5]

Protocol (from reference)

Kinase Assay:[5]
  • kinase assays:

    Inhibition studies of AZD1480 are performed using recombinant Jak1, Jak2, or Jak3 under buffer conditions of 50 mM HEPES pH 7.3, 1 mM DTT, 0.01% Tween-20, 50 mM/ml BSA, and 10 mM MgCl2. Jak3 enzyme is expressed as N-terminal GST fusion in insect cells and purified by glutathione-affinity and size-exclusion chromatographies. Enzymes are assayed in the presence of AZD1480 (10 point dose response, in triplicate, from 8.3 μM to 0.3 nM in half-log dilution steps) using 1.5 μM peptide substrate (Jak1: FITC-C6-KKHTDDGYMPMSPGVA-NH2, Jak2 and Jak3: FAM-SRCtide) and screened under their respective ATP Km (Jak1: 55 μM, Jak2: 15 μM, Jak3: 3 μM) and approximated physiological ATP concentration of 5 mM. Phosphorylated and unphosphorylated peptides are separated and quantified by a Caliper LC3000 system for calculating percent inhibition.

Cell Research:[4]
  • Cell lines: Renca or 786-O cells, mouse endothelial cells and splenic CD11b+/c-myeloid cells, HUVECs
  • Concentrations: ~1 μM
  • Incubation Time: 48 or 24 hours
  • Method: Renca or 786-O cells are suspended in DMEM medium with 5% FBS , and seeded in 96-well plates (5×103 per well) to allow adhesion and then treated with DMSO or AZD1480 for 48 hours. Cell viability is determined by MTS assay. Absorbance at 490 nm is measured with Mikrotek Laborsysteme. Mouse endothelial cells and splenic CD11b+/c- myeloid cells are enriched from tumor-bearing mice,and cultured in 5% FBS RPMI-1640 medium. HUVECs are cultured on collagen 1–coated plates in complete medium. All cells are treated with DMSO and AZD1480 at various doses for 24 hours. Cell viability is determined by counting cell number manually. All the experiments are repeated 3 times.
Animal Research:[4]
  • Animal Models: Female BALB/c and athymic nude (NCR - nu/nu) mice (7–8 weeks old)
  • Dosages: Once a day at the dose of 50 mg/kg or twice daily at 30 mg/kg
  • Administration: Oral gavage

Solubility (25°C)

In vitro

In vivo

Add solvents to the product individually and in order
(Data is from Selleck tests instead of citations):
30% PEG400+0.5% Tween80+5% propylene glycol
For best results, use promptly after mixing.

 5 mg/mL

Chemical Information

Molecular Weight 348.77
Formula

C14H14ClFN8
CAS No. 935666-88-9
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CC1=CC(=NN1)NC2=NC(=NC=C2Cl)NC(C)C3=NC=C(C=N3)F

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT01219543 Terminated Drug: AZD1480 Daily|Drug: AZD1480 BID Solid Tumour|Advanced Solid Malignancies|Child-Pugh A to B7 Advanced Hepatocellular Carcinoma|EGFR and/or ROS Mutant NSCLC|Lung Metastasis Carcinoma|Gastric Cancer AstraZeneca November 2010 Phase 1
NCT01112397 Terminated Drug: AZD1480 Solid Malignancies AstraZeneca April 2010 Phase 1

(data from https://clinicaltrials.gov, updated on 2022-01-17)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy AZD1480|AZD1480 ic50|AZD1480 price|AZD1480 cost|AZD1480 solubility dmso|AZD1480 purchase|AZD1480 manufacturer|AZD1480 research buy|AZD1480 order|AZD1480 mouse|AZD1480 chemical structure|AZD1480 mw|AZD1480 molecular weight|AZD1480 datasheet|AZD1480 supplier|AZD1480 in vitro|AZD1480 cell line|AZD1480 concentration|AZD1480 nmr|AZD1480 in vivo|AZD1480 clinical trial|AZD1480 inhibitor|AZD1480 JAK/STAT inhibitor